{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:31:08Z","timestamp":1786429868151,"version":"build-2736575974"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05200-z","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T09:25:25Z","timestamp":1780737925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding the mechanisms underlying obesity induced tumorigenesis: therapeutic perspectives to manage dysregulated lipid metabolism"],"prefix":"10.1007","volume":"17","author":[{"given":"Uzma","family":"Faridi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashid","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseh A.","family":"Algehainy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyad M.","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faris J.","family":"Tayeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jameel","family":"Barnawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed M.","family":"Jalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik A.","family":"Altayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamdoh","family":"Moawadh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Khalid","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Muzaffar","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaber","family":"Alfaifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Abdullah","family":"Almazni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"issue":"1","key":"5200_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1614362","volume":"377","author":"A Afshin","year":"2017","unstructured":"Afshin A, Forouzanfar MH, Reitsma MB, et al. Health effects of overweight and obesity in 195 countries over 25 years. New England J Med. 2017;377(1):13\u201327. https:\/\/doi.org\/10.1056\/NEJMoa1614362.","journal-title":"New England J Med"},{"issue":"1","key":"5200_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S1470-2045(14)71123-4","volume":"16","author":"M Arnold","year":"2015","unstructured":"Arnold M, Pandeya N, Byrnes G, et al. Global burden of cancer attributable to high body-mass index. Lancet Oncol. 2015;16(1):36\u201346. https:\/\/doi.org\/10.1016\/S1470-2045(14)71123-4.","journal-title":"Lancet Oncol"},{"issue":"18","key":"5200_CR3","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3844","volume":"6","author":"DB Avtanski","year":"2015","unstructured":"Avtanski DB, Nagalingam A, Kuppusamy P, Bonner MY, Arbiser JL, Saxena NK, et al. Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-\u03b2-catenin signaling axis in a microRNA-34a dependent manner. Oncotarget. 2015;6(18):16396. https:\/\/doi.org\/10.18632\/oncotarget.3844.","journal-title":"Oncotarget"},{"issue":"5","key":"5200_CR4","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/ijc.29519","volume":"138","author":"K Balamurugan","year":"2016","unstructured":"Balamurugan K. HIF-1 at the crossroads of hypoxia, inflammation, and cancer. Int J Cancer. 2016;138(5):1058\u201366.","journal-title":"Int J Cancer"},{"issue":"9255","key":"5200_CR5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2012","unstructured":"Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2012;357(9255):539\u201345. https:\/\/doi.org\/10.1016\/S0140-6736(00)04046-0.","journal-title":"Lancet"},{"issue":"7","key":"5200_CR6","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.55730\/1300-0144.6120","volume":"55","author":"T Barlas","year":"2025","unstructured":"Barlas T, Ero\u011flu Altinova A, Co\u015fkun M, Cerit ET. Endocrine disruptors, obesity, and metabolic syndrome. Turk J Med Sci. 2025;55(7):1602\u201312.","journal-title":"Turk J Med Sci"},{"issue":"11","key":"5200_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11111634","volume":"11","author":"CM Bell","year":"2019","unstructured":"Bell CM, Raffeiner P, Hart JR, Vogt PK. PIK3CA cooperates with KRAS to promote MYC activity and tumorigenesis via the bromodomain protein BRD9. Cancers. 2019;11(11):1634.","journal-title":"Cancers"},{"issue":"5","key":"5200_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1210\/er.2017-00073","volume":"38","author":"A Belfiore","year":"2017","unstructured":"Belfiore A, et al. Insulin receptor isoforms in physiology and disease. Endocr Rev. 2017;38(5):379\u2013431. https:\/\/doi.org\/10.1210\/er.2017-00073.","journal-title":"Endocr Rev"},{"issue":"2","key":"5200_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.7570\/jomes25010","volume":"34","author":"JP Bennett","year":"2025","unstructured":"Bennett JP, Lim S. The critical role of body composition assessment in advancing research and clinical health risk assessment across the lifespan. J Obes Metab Syndr. 2025;34(2):120.","journal-title":"J Obes Metab Syndr"},{"issue":"1","key":"5200_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13058-018-1029-4","volume":"20","author":"M Bousquenaud","year":"2018","unstructured":"Bousquenaud M, Fico F, Solinas G, R\u00fcegg C, Santamaria-Mart\u00ednez A. Obesity promotes the expansion of metastasis-initiating cells in breast cancer. Breast Cancer Res. 2018;20(1):104.","journal-title":"Breast Cancer Res"},{"issue":"9945","key":"5200_CR11","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S0140-6736(14)60892-8","volume":"384","author":"K Bhaskaran","year":"2014","unstructured":"Bhaskaran K, Douglas I, Forbes H, dos Santos Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers. Lancet. 2014;384(9945):755\u201365. https:\/\/doi.org\/10.1016\/S0140-6736(14)60892-8.","journal-title":"Lancet"},{"issue":"7","key":"5200_CR12","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.2741\/e562","volume":"4","author":"KA Brown","year":"2012","unstructured":"Brown KA, Simpson ER. Obesity and breast cancer: mechanisms and therapeutic implications. Front Biosci. 2012;4(7):2515\u201324. https:\/\/doi.org\/10.2741\/e562.","journal-title":"Front Biosci"},{"issue":"4","key":"5200_CR13","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.cell.2017.04.004","volume":"169","author":"MD Buck","year":"2017","unstructured":"Buck MD, Sowell RT, Kaech SM, Pearce EL. Metabolic instruction of immunity. Cell. 2017;169(4):570\u201386. https:\/\/doi.org\/10.1016\/j.cell.2017.04.004.","journal-title":"Cell"},{"issue":"2","key":"5200_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.tem.2011.10.003","volume":"23","author":"SE Bulun","year":"2012","unstructured":"Bulun SE, Chen D, Moy I, Brooks DC, Zhao H. Aromatase, breast cancer and obesity: a complex interaction. Trends Endocrinol Metab. 2012;23(2):83\u20139.","journal-title":"Trends Endocrinol Metab"},{"issue":"8","key":"5200_CR15","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrc1408","volume":"4","author":"EE Calle","year":"2004","unstructured":"Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence. Nat Rev Cancer. 2004;4(8):579\u201391. https:\/\/doi.org\/10.1038\/nrc1408.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"5200_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nri1350","volume":"4","author":"AL Cava","year":"2004","unstructured":"Cava AL, Matarese G. The weight of leptin in immunity. Nat Rev Immunol. 2004;4(5):371\u20139.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"5200_CR17","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1158\/1055-9965.EPI-14-0160","volume":"25","author":"DS Chan","year":"2014","unstructured":"Chan DS, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, et al. Body mass index and survival in women with breast cancer\u2014systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014;25(10):1901\u201314. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-0160.","journal-title":"Ann Oncol"},{"key":"5200_CR18","doi-asserted-by":"publisher","DOI":"10.1080\/01480545.2025.2553869","author":"L Chen","year":"2025","unstructured":"Chen L, Sun L. Bisphenol A exposure and its impact on childhood obesity: a molecular and genetic perspective. Drug Chem Toxicol. 2025. https:\/\/doi.org\/10.1080\/01480545.2025.2553869.","journal-title":"Drug Chem Toxicol"},{"issue":"12","key":"5200_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70494","volume":"6","author":"T Chen","year":"2025","unstructured":"Chen T, Zhai W, Song J, Liu W, Wu Z, Yang F, et al. Obesity paradox in cancer: a complex interplay between risk and therapeutic outcomes. MedComm. 2025;6(12):e70494. https:\/\/doi.org\/10.1002\/mco2.70494.","journal-title":"MedComm"},{"issue":"1","key":"5200_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W. Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):70.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"5200_CR21","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1210\/en.2009-0070","volume":"150","author":"MP Cleary","year":"2009","unstructured":"Cleary MP, Grossmann ME. Obesity and breast cancer: the estrogen connection. Endocrinology. 2009;150(6):2537\u201342. https:\/\/doi.org\/10.1210\/en.2009-0070.","journal-title":"Endocrinology"},{"issue":"11","key":"5200_CR22","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1194\/jlr.M500294-JLR200","volume":"46","author":"S Cinti","year":"2005","unstructured":"Cinti S, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005;46(11):2347\u201355. https:\/\/doi.org\/10.1194\/jlr.M500294-JLR200.","journal-title":"J Lipid Res"},{"issue":"2","key":"5200_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000728","volume":"8","author":"A Cortellini","year":"2019","unstructured":"Cortellini A, et al. Body mass index in cancer patients treated with immune checkpoint inhibitors. J Immunother Cancer. 2019;8(2):e000728. https:\/\/doi.org\/10.1136\/jitc-2020-000728.","journal-title":"J Immunother Cancer"},{"issue":"6117","key":"5200_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1126\/science.1232227","volume":"339","author":"LM Coussens","year":"2013","unstructured":"Coussens LM, Zitvogel L, Palucka AK. Neutralizing tumor-promoting chronic inflammation. Science. 2013;339(6117):286\u201391. https:\/\/doi.org\/10.1126\/science.1232227.","journal-title":"Science"},{"key":"5200_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2025.106009","volume":"104","author":"J Crosthwait","year":"2025","unstructured":"Crosthwait J, Syeddan S, Atlas E. The obesogenic effects of Bisphenol A and its analogues are differentially regulated via PPAR\u03b3 transactivation in mouse 3T3-L1 cells. Toxicol In Vitro. 2025;104:106009.","journal-title":"Toxicol In Vitro"},{"issue":"4","key":"5200_CR26","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1210\/er.2011-1015","volume":"33","author":"M Dalamaga","year":"2012","unstructured":"Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer. Endocr Rev. 2012;33(4):547\u201394. https:\/\/doi.org\/10.1210\/er.2011-1015.","journal-title":"Endocr Rev"},{"issue":"4","key":"5200_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/onco5040047","volume":"5","author":"AD Cunha","year":"2025","unstructured":"Cunha AD, Carrilho LAO, NunesFilho PRS, Cantini L, Vidal L, Mendes MCS, et al. The role of metabolic inflammation and insulin resistance in obesity-associated carcinogenesis\u2013a narrative review. Onco. 2025;5(4):47. https:\/\/doi.org\/10.3390\/onco5040047.","journal-title":"Onco"},{"issue":"1","key":"5200_CR28","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1186\/s12905-023-02543-5","volume":"23","author":"T Dehesh","year":"2023","unstructured":"Dehesh T, Fadaghi S, Seyedi M, Abolhadi E, Ilaghi M, Shams P, et al. The relation between obesity and breast cancer risk in women by considering menstruation status and geographical variations: a systematic review and meta-analysis. BMC Womens Health. 2023;23(1):392.","journal-title":"BMC Womens Health"},{"key":"5200_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102657","volume":"65","author":"B Deshmukh","year":"2026","unstructured":"Deshmukh B, Ajay AK, Bhat MK. Obesity and cancer: relevance of DNA damage response. Transl Oncol. 2026;65:102657.","journal-title":"Transl Oncol"},{"issue":"3","key":"5200_CR30","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1530\/JME-12-0007","volume":"48","author":"RJ Dowling","year":"2012","unstructured":"Dowling RJ, Niraula S, Stambolic V, Goodwin PJ. Metformin in cancer: translational challenges. J Mol Endocrinol. 2012;48(3):R31-43. https:\/\/doi.org\/10.1530\/JME-12-0007.","journal-title":"J Mol Endocrinol"},{"issue":"11","key":"5200_CR31","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrc3611","volume":"13","author":"E Elinav","year":"2013","unstructured":"Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13(11):759\u201371. https:\/\/doi.org\/10.1038\/nrc3611.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"5200_CR32","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1136\/gut.2010.235754","volume":"60","author":"H Endo","year":"2011","unstructured":"Endo H, Hosono K, Uchiyama T, Sakai E, Sugiyama M, Takahashi H, et al. Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis. Gut. 2011;60(10):1363\u201371. https:\/\/doi.org\/10.1136\/gut.2010.235754.","journal-title":"Gut"},{"issue":"7503","key":"5200_CR33","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","volume":"330","author":"JM Evans","year":"2005","unstructured":"Evans JM, et al. Metformin and reduced cancer risk. BMJ. 2005;330(7503):1304\u20135. https:\/\/doi.org\/10.1136\/bmj.38415.708634.F7.","journal-title":"BMJ"},{"issue":"1","key":"5200_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cmet.2015.12.015","volume":"23","author":"J Font-Burgada","year":"2016","unstructured":"Font-Burgada J, Sun B, Karin M. Obesity and cancer: the oil that feeds the flame. Cell Metab. 2016;23(1):48\u201362. https:\/\/doi.org\/10.1016\/j.cmet.2015.12.015.","journal-title":"Cell Metab"},{"issue":"1","key":"5200_CR35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev-cancerbio-","volume":"4","author":"A Francou","year":"2020","unstructured":"Francou A, Anderson KV. The epithelial-to-mesenchymal transition in development and cancer. Annu Rev Cancer Biol. 2020;4(1):197\u2013220. https:\/\/doi.org\/10.1146\/annurev-cancerbio-.","journal-title":"Annu Rev Cancer Biol"},{"issue":"1","key":"5200_CR36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2209973120","volume":"120","author":"F Fournier","year":"2023","unstructured":"Fournier F, Diaz-Marin R, Pilon F, Neault M, Juneau R, Girouard G, et al. Obesity triggers tumoral senescence and renders poorly immunogenic malignancies amenable to senolysis. Proc Nat Acad Sci. 2023;120(1):e2209973120.","journal-title":"Proc Nat Acad Sci"},{"issue":"6371","key":"5200_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, et al. Gut microbiome modulates response to anti\u2013PD-1 immunotherapy in melanoma patients. Science. 2018;359(6371):97\u2013103. https:\/\/doi.org\/10.1126\/science.aan4236.","journal-title":"Science"},{"issue":"1","key":"5200_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00030.2014","volume":"100","author":"EJ Gallagher","year":"2015","unstructured":"Gallagher EJ, LeRoith D. Obesity and diabetes: cancer risk and mortality. Physiol Rev. 2015;100(1):1\u201352. https:\/\/doi.org\/10.1152\/physrev.00030.2014.","journal-title":"Physiol Rev"},{"issue":"19","key":"5200_CR39","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1158\/0008-5472.CAN-12-1223","volume":"72","author":"D Gao","year":"2012","unstructured":"Gao D, Vahdat LT, Wong S, Chang JC, Mittal V. Microenvironmental regulation of epithelial\u2013mesenchymal transitions in cancer. Cancer Res. 2012;72(19):4883\u20139. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-1223.","journal-title":"Cancer Res"},{"issue":"7","key":"5200_CR40","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.2337\/dc10-0666","volume":"33","author":"E Giovannucci","year":"2010","unstructured":"Giovannucci E, et al. Diabetes and cancer: a consensus report. Diabetes Care. 2010;33(7):1674\u201385. https:\/\/doi.org\/10.2337\/dc10-0666.","journal-title":"Diabetes Care"},{"issue":"6","key":"5200_CR41","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883\u201399. https:\/\/doi.org\/10.1016\/j.cell.2010.01.025.","journal-title":"Cell"},{"issue":"1","key":"5200_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12979-023-00378-0","volume":"20","author":"LK Grun","year":"2023","unstructured":"Grun LK, Maurmann RM, Scholl JN, Foga\u00e7a ME, Schmitz CRR, Dias CK, et al. Obesity drives adipose-derived stem cells into a senescent and dysfunctional phenotype associated with P38MAPK\/NF-KB axis. Immun Ageing. 2023;20(1):51.","journal-title":"Immun Ageing"},{"issue":"3","key":"5200_CR43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41591-019-0377-7","volume":"25","author":"BA Helmink","year":"2019","unstructured":"Helmink BA, et al. The microbiome, cancer, and cancer therapy. Nat Med. 2019;25(3):377\u201388. https:\/\/doi.org\/10.1038\/s41591-019-0377-7.","journal-title":"Nat Med"},{"issue":"5","key":"5200_CR44","doi-asserted-by":"publisher","first-page":"E877","DOI":"10.1152\/ajpendo.00626.2010","volume":"300","author":"Q He","year":"2011","unstructured":"He Q, Gao Z, Yin J, Zhang J, Yun Z, Ye J. Regulation of HIF-1\u03b1 activity in adipose tissue by obesity-associated factors: adipogenesis, insulin, and hypoxia. Am J Physiol Endocrinol Metab. 2011;300(5):E877\u201385.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1-2","key":"5200_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mce.2012.04.011","volume":"378","author":"EJ Henriksen","year":"2013","unstructured":"Henriksen EJ, Prasannarong M. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle. Mol Cell Endocrinol. 2013;378(1\u20132):15\u201322.","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"5200_CR46","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMra1514009","volume":"376","author":"SB Heymsfield","year":"2017","unstructured":"Heymsfield SB, Wadden TA. Mechanisms and management of obesity. N Engl J Med. 2017;376(3):254\u201366. https:\/\/doi.org\/10.1056\/NEJMra1514009.","journal-title":"N Engl J Med"},{"issue":"3","key":"5200_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","volume":"33","author":"T Hirano","year":"2021","unstructured":"Hirano T. IL-6 in inflammation, autoimmunity and cancer. Int Immunol. 2021;33(3):127\u201348.","journal-title":"Int Immunol"},{"issue":"2","key":"5200_CR48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","volume":"20","author":"G Hoxhaj","year":"2020","unstructured":"Hoxhaj G, Manning BD. The PI3K\u2013AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer. 2020;20(2):74\u201388.","journal-title":"Nat Rev Cancer"},{"issue":"33","key":"5200_CR49","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1200\/JCO.20.00611","volume":"38","author":"BD Hopkins","year":"2016","unstructured":"Hopkins BD, Goncalves MD, Cantley LC. Obesity and cancer metabolism. J Clin Oncol. 2016;38(33):3774\u201382. https:\/\/doi.org\/10.1200\/JCO.20.00611.","journal-title":"J Clin Oncol"},{"issue":"7640","key":"5200_CR50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature21363","volume":"542","author":"GS Hotamisligil","year":"2017","unstructured":"Hotamisligil GS. Inflammation and immunometabolic disorders. Nature. 2017;542(7640):177\u201385. https:\/\/doi.org\/10.1038\/nature21363.","journal-title":"Nature"},{"issue":"1","key":"5200_CR51","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1749-6632.2012.06737.x","volume":"1271","author":"SD Hursting","year":"2012","unstructured":"Hursting SD, Dunlap SM. Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue. Ann N Y Acad Sci. 2012;1271(1):82\u20137. https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06737.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"31","key":"5200_CR52","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1200\/JCO.2016.67.4283","volume":"37","author":"NM Iyengar","year":"2019","unstructured":"Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA. Obesity and cancer mechanisms. J Clin Oncol. 2019;37(31):2751\u201360. https:\/\/doi.org\/10.1200\/JCO.2016.67.4283.","journal-title":"J Clin Oncol"},{"key":"5200_CR53","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1677\/ERC-09-0043","volume":"16","author":"T Jard\u00e9","year":"2009","unstructured":"Jard\u00e9 T, Caldefie-Chezet F, Goncalves-Mendes N, et al. Involvement of adiponectin and leptin in breast cancer: clinical andin vitro studies. Endocr-Relat Cancer. 2009;16:1197\u2013210. https:\/\/doi.org\/10.1677\/ERC-09-0043.","journal-title":"Endocr-Relat Cancer"},{"key":"5200_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2025.118401","volume":"299","author":"M Jaskulak","year":"2025","unstructured":"Jaskulak M, Zimowska M, Rolbiecka M, Zorena K. Understanding the role of endocrine disrupting chemicals as environmental obesogens in the obesity epidemic: a comprehensive overview of epidemiological studies between 2014 and 2024. Ecotoxicol Environ Saf. 2025;299:118401.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"4","key":"5200_CR55","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR. Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15(4):234\u201348. https:\/\/doi.org\/10.1038\/nrclinonc.2018.8.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"5200_CR56","volume":"2015","author":"S Joshi","year":"2015","unstructured":"Joshi S, Liu M, Turner N. Diabetes and its link with cancer: providing the fuel and spark to launch an aggressive growth regime. BioMed Res Int. 2015;2015(1):390863.","journal-title":"BioMed Res Int"},{"issue":"Suppl. 1","key":"5200_CR57","first-page":"84A","volume":"70","author":"M Karsdal","year":"2019","unstructured":"Karsdal M, Reese-Petersen A, Nielsen MJ, Krag A, Thiele M, Gudmann N, et al. The pro-peptide of type VI collagen (endotrophin) is equipotent to Tgf-B in inducing fibrosis: identification of a self-perpetuating vicious cycle driving fibrosis mediated by collagen signals. Hepatology. 2019;70(Suppl. 1):84A-85A.","journal-title":"Hepatology"},{"issue":"5","key":"5200_CR58","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/bjc.2011.254","volume":"105","author":"TJ Key","year":"2011","unstructured":"Key TJ, et al. Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer. 2011;105(5):709. https:\/\/doi.org\/10.1038\/bjc.2011.254.","journal-title":"Br J Cancer"},{"issue":"12","key":"5200_CR59","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nrc3174","volume":"11","author":"MJ Khandekar","year":"2011","unstructured":"Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer. 2011;11(12):886\u201395. https:\/\/doi.org\/10.1038\/nrc3174.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"5200_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27042066","volume":"27","author":"N Kurhaluk","year":"2026","unstructured":"Kurhaluk N, Ko\u0142odziejska R, Mazur Z, Lukash O, Yakovenko O, Tkaczenko H. Functional foods as modulators of epigenetic mechanisms affecting metabolic health in adolescence. Int J Mol Sci. 2026;27(4):2066.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"5200_CR61","first-page":"1445","volume":"15","author":"T Kusaba","year":"2006","unstructured":"Kusaba T, Nakayama T, Yamazumi K, Yakata Y, Yoshizaki A, Inoue K, et al. Activation of STAT3 is a marker of poor prognosis in human colorectal cancer. Oncol Rep. 2006;15(6):1445\u201351.","journal-title":"Oncol Rep"},{"issue":"1","key":"5200_CR62","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3322\/caac.20140","volume":"62","author":"LH Kushi","year":"2012","unstructured":"Kushi LH, et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention. CA Cancer J Clin. 2012;62(1):30\u201367. https:\/\/doi.org\/10.3322\/caac.20140.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5200_CR63","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.smim.2014.01.002","volume":"26","author":"M Lesina","year":"2014","unstructured":"Lesina M, W\u00f6rmann SM, Neuh\u00f6fer P, Song L, Alg\u00fcl H. Interleukin-6 in inflammatory and malignant diseases of the pancreas. Semin Immunol. 2014;26(1):80\u20137. https:\/\/doi.org\/10.1016\/j.smim.2014.01.002.","journal-title":"Semin Immunol"},{"issue":"2","key":"5200_CR64","first-page":"428","volume":"61","author":"CY Li","year":"2001","unstructured":"Li CY, Little JB, Hu K, Zhang W, Zhang L, Dewhirst MW, et al. Persistent genetic instability in cancer cells induced by non-DNA-damaging stress exposures. Cancer Res. 2001;61(2):428\u201332.","journal-title":"Cancer Res"},{"issue":"22","key":"5200_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225684","volume":"14","author":"J Li","year":"2022","unstructured":"Li J, Xu R. Obesity-associated ECM remodeling in cancer progression. Cancers. 2022;14(22):5684.","journal-title":"Cancers"},{"issue":"31","key":"5200_CR66","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1200\/JCO.2014.58.4680","volume":"32","author":"JA Ligibel","year":"2014","unstructured":"Ligibel JA, Alfano CM, Courneya KS, Demark-Wahnefried W, Burger RA, Chlebowski RT, et al. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol. 2014;32(31):3568\u201374. https:\/\/doi.org\/10.1200\/JCO.2014.58.4680.","journal-title":"J Clin Oncol"},{"issue":"3","key":"5200_CR67","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S1470-2045(18)30078-0","volume":"19","author":"JL McQuade","year":"2018","unstructured":"McQuade JL, Daniel CR, Hess KR, Mak C, Wang DY, Rai RR, et al. Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. Lancet Oncol. 2018;19(3):310\u201322. https:\/\/doi.org\/10.1016\/S1470-2045(18)30078-0.","journal-title":"Lancet Oncol"},{"issue":"1","key":"5200_CR68","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev-immunol-032712-095956","volume":"31","author":"NJ MacIver","year":"2013","unstructured":"MacIver NJ, Michalek RD, Rathmell JC. Metabolic regulation of T lymphocytes. Annu Rev Immunol. 2013;31(1):259\u201383. https:\/\/doi.org\/10.1146\/annurev-immunol-032712-095956.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"5200_CR69","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704\u201315. https:\/\/doi.org\/10.1016\/j.cell.2008.03.027.","journal-title":"Cell"},{"issue":"5","key":"5200_CR70","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1128\/MCB.19.5.3916","volume":"19","author":"J Mitra","year":"1999","unstructured":"Mitra J, Dai CY, Somasundaram K, El-Deiry WS, Satyamoorthy K, Herlyn M, et al. Induction of p21 WAF1\/CIP1 and inhibition of Cdk2 mediated by the tumor suppressor p16 INK4a. Mol Cell Biol. 1999;19(5):3916\u201328.","journal-title":"Mol Cell Biol"},{"key":"5200_CR71","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1467-789X.2012.01033.x","volume":"13","author":"MJ M\u00fcller","year":"2012","unstructured":"M\u00fcller MJ, Lagerpusch M, Enderle J, Schautz B, Heller M, Bosy-Westphal A. Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome. Obes Rev. 2012;13:6\u201313.","journal-title":"Obes Rev"},{"issue":"2","key":"5200_CR72","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.70188","volume":"44","author":"I Nait Irahal","year":"2026","unstructured":"Nait Irahal I, Chbel A, Lafnoune A, Darkaoui B, Wahnou H. adipose tissue extracellular matrix remodeling: a driver of obesity and insulin resistance. Cell Biochem Funct. 2026;44(2):e70188.","journal-title":"Cell Biochem Funct"},{"issue":"13","key":"5200_CR73","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1161\/CIRCULATIONAHA.117.029617","volume":"137","author":"IJ Neeland","year":"2018","unstructured":"Neeland IJ, Poirier P, Despr\u00e9s JP. Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management. Circulation. 2018;137(13):1391\u2013406.","journal-title":"Circulation"},{"issue":"1","key":"5200_CR74","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/658913","volume":"2014","author":"E Nigro","year":"2014","unstructured":"Nigro E, Scudiero O, Monaco ML, Palmieri A, Mazzarella G, Costagliola C, et al. New insight into adiponectin role in obesity and obesity-related diseases. BioMed Res Int. 2014;2014(1):658913. https:\/\/doi.org\/10.1155\/2014\/658913.","journal-title":"BioMed Res Int"},{"issue":"7","key":"5200_CR75","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/cells14070488","volume":"14","author":"A Nishida","year":"2025","unstructured":"Nishida A, Andoh A. The role of inflammation in cancer: mechanisms of tumor initiation, progression, and metastasis. Cells. 2025;14(7):488.","journal-title":"Cells"},{"issue":"2","key":"5200_CR76","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jacl.2011.02.001","volume":"5","author":"JD Otvos","year":"2011","unstructured":"Otvos JD, Mora S, Shalaurova I, Greenland P, Mackey RH, Goff DC Jr. Clinical implications of discordance between low-density lipoprotein cholesterol and particle number. J Clin Lipidol. 2011;5(2):105\u201313. https:\/\/doi.org\/10.1016\/j.jacl.2011.02.001.","journal-title":"J Clin Lipidol"},{"issue":"1","key":"5200_CR77","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.immuni.2014.06.005","volume":"41","author":"D O\u2019Sullivan","year":"2014","unstructured":"O\u2019Sullivan D, van der Windt GJ, Huang SCC, Curtis JD, Chang CH, Buck MD, et al. Memory CD8+ T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity. 2014;41(1):75\u201388.","journal-title":"Immunity"},{"key":"5200_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.878280","volume":"13","author":"P P\u00e1nico","year":"2022","unstructured":"P\u00e1nico P, Velasco M, Salazar AM, Picones A, Ortiz-Huidobro RI, Guerrero-Palomo G, et al. Is arsenic exposure a risk factor for metabolic syndrome? A review of the potential mechanisms. Front Endocrinol. 2022;13:878280.","journal-title":"Front Endocrinol"},{"issue":"1","key":"5200_CR79","doi-asserted-by":"publisher","DOI":"10.38212\/2224-6614.2091","volume":"20","author":"JHY Park","year":"2012","unstructured":"Park JHY, Kang YH, Sung MK, Kwon DY, Yang Y. Diet-induced obesity, inflammation, and cancer. J Food Drug Anal. 2012;20(1):25. https:\/\/doi.org\/10.38212\/2224-6614.2091.","journal-title":"J Food Drug Anal"},{"issue":"8","key":"5200_CR80","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrendo.2014.94","volume":"10","author":"J Park","year":"2014","unstructured":"Park J, Morley TS, Kim M, Clegg DJ, Scherer PE. Obesity and cancer\u2014mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol. 2014;10(8):455\u201365. https:\/\/doi.org\/10.1038\/nrendo.2014.94.","journal-title":"Nat Rev Endocrinol"},{"key":"5200_CR81","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ygyno.2025.12.001","volume":"204","author":"B Patterson","year":"2026","unstructured":"Patterson B, Sinha N, Broaddus E, Stocks S, Zamboni W, Albright BB, et al. Associations between obesity and outcomes in pembrolizumab-treated endometrial cancer. Gynecol Oncol. 2026;204:228\u201334.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"5200_CR82","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrendo.2013.256","volume":"10","author":"I Pernicova","year":"2014","unstructured":"Pernicova I, Korbonits M. Metformin mode of action. Nat Rev Endocrinol. 2014;10(3):143\u201356. https:\/\/doi.org\/10.1038\/nrendo.2013.256.","journal-title":"Nat Rev Endocrinol"},{"key":"5200_CR83","doi-asserted-by":"publisher","DOI":"10.1177\/17588359251363104","volume":"17","author":"M Pienia\u0327\u017cek","year":"2025","unstructured":"Pienia\u0327\u017cek M, Polakiewicz-Gilowska A, Las-Jankowska M, Wronowicz J, Jarza\u0327b M, \u0141acko A, et al. Weight change and BMI are not prognostic markers of survival outcomes in sacituzumab govitecan therapy for mTNBC in the Polish female cohort. Ther Adv Med Oncol. 2025;17:17588359251363104.","journal-title":"Ther Adv Med Oncol"},{"issue":"12","key":"5200_CR84","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrc2536","volume":"8","author":"M Pollak","year":"2008","unstructured":"Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008;8(12):915\u201328. https:\/\/doi.org\/10.1038\/nrc2536.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"5200_CR85","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1038\/oby.2010.59","volume":"18","author":"SR Preis","year":"2010","unstructured":"Preis SR, Massaro JM, Robins SJ, Hoffmann U, Vasan RS, Irlbeck T, et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham Heart Study. Obesity Silver Spring. 2010;18(11):2191\u20138.","journal-title":"Obesity Silver Spring"},{"issue":"3","key":"5200_CR86","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41574-018-0126-x","volume":"15","author":"DF Quail","year":"2019","unstructured":"Quail DF, Dannenberg AJ. Obese adipose tissue microenvironment in cancer. Nat Rev Endocrinol. 2019;15(3):139\u201354. https:\/\/doi.org\/10.1038\/s41574-018-0126-x.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"5200_CR87","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ghir.2004.01.005","volume":"14","author":"YH Ibrahim","year":"2004","unstructured":"Ibrahim YH, Yee D. Insulin-like growth factor-I and cancer risk. Growth Horm IGF Res. 2004;14(4):261\u20139.","journal-title":"Growth Horm IGF Res"},{"key":"5200_CR88","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bcp.2019.01.006","volume":"161","author":"PK Raut","year":"2019","unstructured":"Raut PK, Kim SH, Choi DY, Jeong GS, Park PH. Growth of breast cancer cells by leptin is mediated via activation of the inflammasome: critical roles of estrogen receptor signaling and reactive oxygen species production. Biochem Pharmacol. 2019;161:73\u201388.","journal-title":"Biochem Pharmacol"},{"key":"5200_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1560080","volume":"12","author":"ARDF Rocha","year":"2025","unstructured":"Rocha ARDF, Morais NDSD, Azevedo FM, Morais DDC, Pereira PF, Peluzio MDCG, et al. Leptin, CRP, and adiponectin correlate with body fat percentage in adolescents: systematic review and meta-analysis. Front Nutr. 2025;12:1560080.","journal-title":"Front Nutr"},{"issue":"4","key":"5200_CR90","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3322\/caac.21591","volume":"70","author":"CL Rock","year":"2020","unstructured":"Rock CL, et al. Nutrition and physical activity guidelines for cancer survivors. CA. 2020;70(4):245\u201371. https:\/\/doi.org\/10.3322\/caac.21591.","journal-title":"CA"},{"issue":"4","key":"5200_CR91","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3390\/nu10040432","volume":"10","author":"MM Rogero","year":"2018","unstructured":"Rogero MM, Calder PC. Obesity, inflammation, toll-like receptor 4 and fatty acids. Nutrients. 2018;10(4):432.","journal-title":"Nutrients"},{"issue":"723","key":"5200_CR92","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf9382","volume":"15","author":"MW Schleh","year":"2023","unstructured":"Schleh MW, Caslin HL, Garcia JN, Mashayekhi M, Srivastava G, Bradley AB, et al. Metaflammation in obesity and its therapeutic targeting. Sci Transl Med. 2023;15(723):eadf9382.","journal-title":"Sci Transl Med"},{"issue":"3","key":"5200_CR93","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/17425255.2018.1440287","volume":"14","author":"C Smit","year":"2018","unstructured":"Smit C, De Hoogd S, Br\u00fcggemann RJ, Knibbe CA. Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters. Expert Opin Drug Metab Toxicol. 2018;14(3):275\u201385.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"21","key":"5200_CR94","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.3390\/cancers15215135","volume":"15","author":"M Spanoudaki","year":"2023","unstructured":"Spanoudaki M, Giaginis C, Karafyllaki D, Papadopoulos K, Solovos E, Antasouras G, et al. Exercise as a promising agent against cancer: evaluating its anti-cancer molecular mechanisms. Cancers. 2023;15(21):5135.","journal-title":"Cancers"},{"key":"5200_CR95","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.80418","author":"NL Swathi","year":"2025","unstructured":"Swathi NL, Shakhatreh Z, Tahir A, Singh J, Sulaiman S, Athul H, et al. Epigenetic mechanisms in the transfer of metabolic disorders: a comprehensive review. Cureus. 2025. https:\/\/doi.org\/10.7759\/cureus.80418.","journal-title":"Cureus"},{"issue":"2","key":"5200_CR96","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/path.3000","volume":"226","author":"ML Taddei","year":"2012","unstructured":"Taddei ML, Giannoni E, Fiaschi T, Chiarugi P. Anoikis: an emerging hallmark in health and diseases. J Pathol. 2012;226(2):380\u201393.","journal-title":"J Pathol"},{"issue":"12","key":"5200_CR97","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s40618-016-0508-7","volume":"39","author":"R Vigneri","year":"2016","unstructured":"Vigneri R, Goldfine ID, Frittitta L. Insulin, insulin receptors, and cancer. J Endocrinol Invest. 2016;39(12):1365\u201376. https:\/\/doi.org\/10.1007\/s40618-016-0508-7.","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"5200_CR98","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1158\/1078-0432.CCR-12-0930","volume":"19","author":"MN VanSaun","year":"2013","unstructured":"VanSaun MN. Molecular pathways: adiponectin and leptin signaling in cancer. Clin Cancer Res. 2013;19(8):1926\u201332. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0930.","journal-title":"Clin Cancer Res"},{"key":"5200_CR99","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cytogfr.2022.07.008","volume":"69","author":"M Vliora","year":"2023","unstructured":"Vliora M, Ravelli C, Grillo E, Corsini M, Flouris AD, Mitola S. The impact of adipokines on vascular networks in adipose tissue. Cytokine Growth Factor Rev. 2023;69:61\u201372.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"5200_CR100","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1039\/D3FO05148J","volume":"15","author":"N Wang","year":"2024","unstructured":"Wang N, Huo Y, Gao X, Li Y, Cheng F, Zhang Z. Lead exposure exacerbates liver injury in high-fat diet-fed mice by disrupting the gut microbiota and related metabolites. Food Funct. 2024;15(6):3060\u201375.","journal-title":"Food Funct"},{"issue":"3","key":"5200_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.102241","volume":"9","author":"H Wen","year":"2024","unstructured":"Wen H, Deng G, Shi X, Liu Z, Lin A, Cheng Q, et al. Body mass index, weight change, and cancer prognosis: a meta-analysis and systematic review of 73 cohort studies. ESMO Open. 2024;9(3):102241. https:\/\/doi.org\/10.1016\/j.esmoop.2024.102241.","journal-title":"ESMO Open"},{"key":"5200_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.08.012","author":"G Wei","year":"2021","unstructured":"Wei G, Sun H, Dong K, Hu L, Wang Q, Zhuang Q, et al. The thermogenic activity of adjacent adipocytes fuels the progression of ccRCC and compromises anti-tumor therapeutic efficacy. Cell Metab. 2021. https:\/\/doi.org\/10.1016\/j.cmet.2021.08.012.","journal-title":"Cell Metab"},{"key":"5200_CR103","unstructured":"World Health Organization. 2022. Obesity and overweight. WHO."},{"issue":"7","key":"5200_CR104","doi-asserted-by":"publisher","DOI":"10.1002\/ajhb.23743","volume":"34","author":"SP Waterworth","year":"2022","unstructured":"Waterworth SP, Kerr CJ, McManus CJ, Costello R, Sandercock GR. Obese individuals do not underreport dietary intake to a greater extent than nonobese individuals when data are allometrically-scaled. Am J Hum Biol. 2022;34(7):e23743.","journal-title":"Am J Hum Biol"},{"issue":"12","key":"5200_CR105","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1158\/1541-7786.MCR-11-0271","volume":"9","author":"A Yadav","year":"2011","unstructured":"Yadav A, Kumar B, Datta J, Teknos TN, Kumar P. IL-6 promotes head and neck tumor metastasis by inducing epithelial\u2013mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res. 2011;9(12):1658\u201367.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"5200_CR106","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/BF02789419","volume":"50","author":"SJ Yiin","year":"1995","unstructured":"Yiin SJ, Lin TH. Lead-catalyzed peroxidation of essential unsaturated fatty acid. Biol Trace Elem Res. 1995;50(2):167\u201372.","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"5200_CR107","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-023-01442-3","volume":"8","author":"M You","year":"2023","unstructured":"You M, Xie Z, Zhang N, Zhang Y, Xiao D, Liu S, et al. Signaling pathways in cancer metabolism: mechanisms and therapeutic targets. Signal Transduct Target Ther. 2023;8(1):196.","journal-title":"Signal Transduct Target Ther"},{"key":"5200_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1147676","volume":"11","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Zhang H, Liao X, Tsai HI. KRAS mutation: the booster of pancreatic ductal adenocarcinoma transformation and progression. Front Cell Dev Biol. 2023;11:1147676.","journal-title":"Front Cell Dev Biol"},{"issue":"6382","key":"5200_CR109","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1126\/science.aar6918","volume":"359","author":"L Zitvogel","year":"2018","unstructured":"Zitvogel L, Ma Y, Raoult D, Kroemer G, Gajewski TF. The microbiome in cancer immunotherapy: diagnostic tools and therapeutic strategies. Science. 2018;359(6382):1366\u201370. https:\/\/doi.org\/10.1126\/science.aar6918.","journal-title":"Science"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05200-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05200-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05200-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:16:58Z","timestamp":1786429018000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05200-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":109,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5200"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05200-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"11 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1149"}}